1. Introduction {#sec1}
===============

Sarcoptic mange is a common, widespread disease of domestic and wild mammals ([@bib48]). The causative agent is *Sarcoptes scabiei*, a microscopic mite that infests the skin of its host by burrowing into the epidermis ([@bib79]). It is an acarid that belongs to the order Sarcoptiformes, which includes other mites of veterinary importance such as *Psoroptes, Knemicodoptes,* and *Notoedres,* among others. In humans, *S. scabiei* causes disease known as scabies, and in animals the disease is referred to as sarcoptic mange ([@bib113]). While not proven, one theory suggests that *S. scabiei* originated as a pathogen of humans with animals serving as aberrant spillover hosts. In this theory, the observed variability in host adaptations of *S. scabiei* is likely the result of continuous interbreeding of the different strains that affect humans and animals ([@bib65], [@bib66]).

In general, the lesions most commonly associated with sarcoptic mange include alopecia, hyperkeratosis, and erythema often accompanied by intense pruritus. Thick skin crusting and fissuring often occur, and many animals die from emaciation or secondary infections with bacteria or yeast ([@bib68]; [@bib149]; [@bib136]; [@bib128]). Mange epizootics have been reported in a variety of host species worldwide. These events are often associated with high morbidity and mortality in wildlife populations, including Cantabrian chamois (*Rupicapra pyrenaica parava*) in Spain, red foxes (*Vulpes vulpes*) in Fennoscandia, and wombats (*Lasiorhinus* sp. and *Vombatus ursinus*) in Australia ([@bib67]; [@bib146]).

Scabies in humans has been recognized since biblical times and was one of the first human diseases with a known etiology. Various treatments in animals, using olive oil, lupine, wine, tar, or grease, were described in Europe and the Middle East between the 1st and 16th centuries. The term *scabies* may have been first used by the Roman physician Celsus, but this is not widely accepted. The etiology of mange was not determined to be a parasite until the 17th century by Bonomo. He and other colleagues made large advances on the biology of *S. scabiei* by describing the two sexes and replication by sexual reproduction. Linnaeus was the first to formally describe and name the mite -- as *Acarus humanus subcutaneous* in man and *Acarus exulcerans* in animals. The rediscovered mite was renamed by Renucci in 1834 to *Acarus scabiei* from a human in Paris. For additional information, multiple reviews on the history of scabies and mange have been published ([@bib75]; [@bib153]; [@bib48]).

Sarcoptic mange is a well-documented and researched disease of wildlife in Europe, Australia, Africa, and Asia ([@bib210]; [@bib119]; [@bib102]; [@bib72]; [@bib135]). Although sarcoptic mange is a common cause of disease in select wildlife species in North America, similar published reports or reviews are lacking. Herein, we review the natural history of *S. scabiei*, including morphology, diagnostics, and research on wildlife species in North America. Research from wildlife outside of North America or in humans is addressed where it can be related to the disease in North American wildlife.

2. Sarcoptes scabiei {#sec2}
====================

2.1. Phylogeny and classification {#sec2.1}
---------------------------------

*Sarcoptes scabiei* (Linnaeus, 1758) is in the superorder Acariformes and order Sarcoptiformes. It is within the superfamily Sarcoptoidea, and family Sarcoptidae. Sarcoptidae contains three subfamilies including Sarcoptinae which consists of four genera, including *Sarcoptes* ([@bib57]; [@bib209]). It has been suggested that *S. scabiei* is a single heterogenous species that exhibits a high degree of host specificity but has some level of cross-infectivity ([@bib182]; [@bib143]; [@bib65]; [@bib11]; [@bib207]). Traditionally, variant forms of *S. scabiei* have been identified based on the host species from which they were detected (e.g. *Sarcoptes scabiei* var*. canis, Sarcoptes scabiei* var. *suis,* etc.) and inability to cause pronounced clinical disease in taxonomically distinct hosts ([@bib64]; [@bib157]; [@bib65]; [@bib11]; [@bib16]; [@bib18]). However, few morphological differences are seen among mites found on different host species ([@bib64]; [@bib65]). Rather, it is believed that the differences between these variants, which define their host preference, are physiologic and/or genetic ([@bib143]). Other than human variants being distinct from the 'animal' clade, genetic studies conducted to date have not been able to consistently distinguish between different host variants using common gene targets for mites including internal transcribed spacer region-2 (ITS-2) and cytochrome oxidase 1 (COI) ([@bib207]; [@bib27]; [@bib169]; [@bib86]; [@bib87]; [@bib141]).

In contrast, consistent clustering in geographic or host specificity can still be obtained using microsatellites and mitochondrial DNA as markers, which shows uncertainty for the usefulness of ITS-2 as a gene for *S. scabiei* phylogenetic analyses ([@bib207]; [@bib201]; [@bib176]; [@bib3]; [@bib151]; [@bib80]). There is potential for microsatellites and mitochondrial DNA to have value, but there is little consistency in which microsatellites or targets are chosen inhibiting the ability to compare large datasets. The *Sarcoptes*-World Molecular Network was created to improve methods of *Sarcoptes* detection as well as provide a central location for comparing phylogenetic data ([@bib4]). A formal consensus on the taxonomy based on morphological and genetic features has not been made other than to suggest that all *Sarcoptes scabiei* variants are the same genetically diverse species ([@bib72]).

2.2. Life cycle {#sec2.2}
---------------

The life cycle of *S. scabiei* consists of five stages: egg, larva, protonymph, tritonymph, and adult ([Fig. 1](#fig1){ref-type="fig"}) ([@bib64]; [@bib14]). Adults create tunnels through the superficial layer of host skin in part accomplished by cutting mouthpieces and hooks on the legs ([Fig. 2](#fig2){ref-type="fig"}A) ([@bib14]). Little is known about the secreted substances the mite may use to help aid in this tunneling process ([@bib10]). Penetration into the epidermis must be achieved for infestation and disease manifestation to occur ([@bib17]). Most tunnels track through the stratum corneum of the epidermis; however, mites can penetrate the stratum granulosum and stratum spinosum in both humans and animals ([Video 1](#mmc1){ref-type="supplementary-material"}) ([@bib121]; [@bib105]). Mites are able to penetrate the skin within 30 min of contact ([@bib10]; [@bib14]).Fig. 1Life stages of *S. scabiei.* Top left: Egg; Top middle: Larva; Top right: Protonymph; Bottom left: Tritonymph; Bottom middle: Adult Male; Bottom right: Adult Female.Fig. 1Fig. 2Microscopic lesions of a bear with sarcoptic mange. (A) Close-up view of hyperkeratotic and crusted skin showing a mite tunnel. (B) Histological section with cross-section of *S. scabiei* within the epidermis. (Asterisks: mite tunnels; arrowheads: epidermis; arrow pointing to *S. scabiei*).Fig. 2

Supplementary video related to this article can be found at [https://doi.org/10.1016/j.ijppaw.2019.06.003](http://doi:10.1016/j.ijppaw.2019.06.003){#intref0010}.

The following is the supplementary data related to this article:videoMultiple life stages of *S. scabiei* moving within mite tunnels, as well as a cluster of eggs, from the skin of a black bear with sarcoptic mange.

Adult females will lay approximately three to four eggs per day, and it is estimated that one mite can produce over 50 eggs during its four to six week life expectancy ([@bib21]). Based on studies using a rabbit model, the larvae hatch from eggs between 50 and 53 h, larvae molt to protonymphs 3--4 days later, and protonymphs to tritonymphs and tritonymphs to adult were both 2--3 days thereafter ([@bib14]). There is likely significant variation in the duration of each life stage based on temperature, humidity, host, and observation methods, but much of this variation and importance of different factors are poorly understood ([@bib21]). Larvae, nymphs, and adult males can also be found in these tunnels ingesting host cells and lymph. The entire life cycle from egg to adult takes approximately two weeks, and all life stages can be found on the same individual host ([@bib14]).

2.3. Morphology {#sec2.3}
---------------

Detailed morphological features were initially described by Fain in 1968. Overall, the *S. scabiei* idiosoma is dorsally convex and ventrally flattened. All four pairs of limbs of the mite are short and stout with the anterior two pairs of limbs extending out beyond the margin of the idiosoma while the posterior two pairs of limbs do not in adults. The tarsi of the anterior two legs have two blade-like claws as well as stalked empodium with distal pads, and the tibiotarsi of the posterior legs have one or two blade-like claws depending on whether the mite is male or female. Extending from the tarsi are long, unsegmented pedicels with bell-like caruncles. These are found on the anterior two pairs of legs in females and on all four pairs of legs in males. Females have long setae extending from their posterior two pairs of legs ([@bib64]; [@bib143]; [@bib43]; [@bib198]).

Cytologically, *S. scabiei* is identified by its characteristic club-like setae on the posterior end of its dorsal idiosoma and by the tooth-like cuticular denticles/spines of the females in the mid-dorsal region of the idiosoma. Both sexes have claws on the terminal segments of all legs as well as have a terminal anus. Transverse, ridged, dorsal striations are present on the idiosoma. These morphologic characteristics distinguish *S. scabiei* from other sarcoptiform mites found on select mammalian hosts such as *Notoedres* spp. (dorsal anus), *Psoroptes* spp. (smooth body, jointed leg stalks, and teardrop-shaped), *Trixacarus caviae* (adult females approximately 200 microns shorter in length), *Ursicoptes* spp. (ovoid to elongated idiosoma), and *Chorioptes* spp. (short pedicels) ([@bib32]; [@bib198]; [@bib206]). *Demodex* spp. are another mite group commonly associated with clinical disease in numerous wild and domestic mammals, but they have a distinct 'cigar-shaped' morphology ([@bib62]).

2.4. Transmission {#sec2.4}
-----------------

Transmission of *S. scabiei*, to any host, occurs via direct and/or indirect contact (i.e. shared environments or fomites) ([@bib175]; [@bib15]; [@bib18]). The importance of each mechanism of transmission likely varies between hosts based on a variety of factors, including host susceptibility and behavior, mite strain, and environmental conditions. Direct contact transmission is often the primary means of transmission in humans ([@bib139]; [@bib41]). In wildlife, the mechanisms of transmission are likely variable and include both direct transmission in social species as well as indirect transmission in more solitary species, but our understanding of mechanisms of transmission in many wildlife species is lacking ([@bib60]; [@bib59]; [@bib6]; [@bib63]). Vertical transmission between adults and offspring has also been reported and occurs after birth ([@bib38], [@bib39]; [@bib9]; [@bib76]). Numerous field-based molecular and experimental studies on the transmission of mites between similar and different hosts, including between animals and humans, have suggested that infestivity and severe disease occurred most commonly when mites were shared between similar hosts rather than between distantly related hosts ([@bib172]; [@bib191]; [@bib163]; [@bib11]; [@bib16]; [@bib30]; [@bib116]).

An important factor influencing the efficiency of indirect transmission is mite survival in the environment. Temperature, humidity, and possibly mite strain are important factors that can affect the ability of mites to survive off of the host, with survival being shortest at temperatures less than 0 °C and above 45 °C and at lower relative humidity (less than 25%); mites survived longest at cool (between 4 and 10 °C) but not freezing temperatures and high (97%) relative humidity ([@bib10]; [@bib18]; [@bib131]). In the environment, mites use multiple cues to seek out new hosts, including temperature and odor ([@bib12]). Additionally, it was shown that mites are likely only able to penetrate the skin and cause subsequent disease between one half to two thirds of its survival time in the environment ([@bib10]; [@bib18]). Simulation models showed that San Juan Kit foxes (*Vulpes macrotis mutica*) likely transmit mites indirectly between family groups using dens rather than direct contact ([@bib117]). Additionally, indirect transmission through shared dens is likely the most dominant mechanism of mite transmission among wombats as well as possibly within and between carnivore species in Europe ([@bib101]; [@bib112]). Evidence of indirect transmission and data showing mite survival off of the live host suggest that scenarios when animals share space, including artificial feeding sites, may contribute to mite transmission ([@bib187]; [@bib131]).

3. Sarcoptic mange {#sec3}
==================

3.1. Clinical signs and pathology {#sec3.1}
---------------------------------

The incubation period (i.e. period from exposure to the development of observable signs or lesions) is dependent on host and the quantity of mite exposure. Experimentally, incubation period has ranged from 6 days in domestic dogs to 30 days in other species ([@bib182]; [@bib120]; [@bib30]; [@bib34]; [@bib36]). The most common clinical signs and gross lesions in all hosts include pruritus, erythema, hyperkeratosis, seborrhea, and alopecia ([@bib34]; [@bib36]; [@bib104]; [@bib22]). However, these signs can result in at least two unique manifestations of mange: 'ordinary' mange characterized by predominately alopecia (in haired mammals) with relatively few mites present, and 'crusted mange' that results in severe hyperkeratosis and serocelluar crusts and is associated with a large mite burden ([@bib146]; [@bib73]). These presentations in humans are often known as 'classical' scabies and 'Norwegian' or 'crusted' scabies, respectively ([@bib19]).

The progression of lesions is largely consistent among experimental infections of dogs, pigs, rabbits, and foxes. The first observable lesions include seborrhea and erythema, followed by crusting and alopecia several days thereafter ([@bib182]; [@bib163]; [@bib36]; [@bib133]). The lesions radiate from the site of infection until hyperkeratosis occurs ([@bib109]). As the disease progresses, similar lesions begin to appear on other parts of the body including the limbs ([@bib182]; [@bib145]; [@bib120]; [@bib36]). As the immune response progresses, pruritus increases while mite burden decreases. Subsequent chronic lesions include skin thickening, lichenification, loss of nutritional condition, secondary bacterial or yeast infections of the skin, and in some cases the animal may become septic ([@bib36]). The intense pruritus results in a dramatic increase in the number and severity of self-inflicted lesions created by the host from licking and scratching at its skin ([@bib163]). Thus, many of the lesions seen in later infestations are due to the manifestation of the hypersensitivity response rather than the mites themselves ([@bib146]). [@bib133] suggested that in foxes, lesions start as focal skin disease and either progress to a severe hyperkeratosis with generalized skin lesions or switch to an alopecic/healing form ([Fig. 2](#fig2){ref-type="fig"}B). The end stages of the disease often show animals with reduced appetite, dehydration, and poor physical condition ([@bib36]; [@bib163]; [@bib111]). Several organisms have been associated with secondary infections in cases of sarcoptic mange including *Malassezia pachydermatis* and *Pelodera strongyloides* although their role in lesions present is largely unknown ([@bib161]; [@bib69]; [@bib142]).

*Sarcoptes* mites produce a variety of antigenic material (e.g. eggshells, molted skins, dead mites, and mite feces) as they penetrate and burrow through the skin of the host ([@bib13]; [@bib118]). The type of immune response is largely dependent on the immune status of the host and if the host can induce an appropriate hypersensitivity response ([@bib146]). Some highly susceptible species (e.g. red foxes) develop a hypersensitivity response to this material, the most common of which is the Type 1 (i.e. immediate response) ([@bib109]; [@bib189]). A Type 4 (i.e. delayed response), where many T-lymphocytes accumulate in the dermis, has been reported in humans, domestic dogs, and pigs and in conjunction with a Type I reaction ([@bib165]; [@bib55]; [@bib35]; [@bib167], [@bib168]; [@bib61]). The Type I hypersensitivity primarily manifests as hyperplasia of mast cells and eosinophils with associated increases in these cell types on blood cell counts ([@bib109]).

3.2. Diagnostic testing and monitoring {#sec3.2}
--------------------------------------

While clinical signs can be suggestive of mange, confirming the disease in individual animals requires one of the following techniques: cytology/histology to identify mites and describe the associated pathology, detection of antibodies in the serum, and/or molecular techniques ([@bib7]). Sarcoptic mange can grossly appear similar to other skin diseases, and identification of mites, typically by skin scrape or biopsy, is necessary to make an accurate diagnosis in both humans and animals ([@bib91]; [@bib49]). In addition, mange can be caused by different species, even genera, of mites in individual host species so morphologic or molecular identification of mites is important. For example, mange in black bears (*Ursus americanus*) can be caused by *S. scabiei*, *Ursicoptes americanus*, and *Demodex ursi* ([@bib206]; [@bib58]; [@bib142]). While skin scrapes are the most commonly used method for diagnosing mange, variation in mite burden and host response between species may result in inconsistencies for this diagnostic approach ([@bib109]; [@bib74], [@bib73]; [@bib142]). For example, in canids, the mite burden is generally low even in severely affected animals and consequently cytology may not be effective at detecting mites in these hosts ([@bib163]; [@bib91]). In other species (e.g. pigs, humans, and bears) mite burdens are higher with similar or less severe clinical signs, resulting in higher success of detection of mites via cytology ([@bib55]; [@bib199]; [@bib142]).

Characteristic histological lesions, including eosinophilic or lymphocytic dermatitis, acanthosis, and severe parakeratotic hyperkeratosis can help support a diagnosis of mange. While seeing cross-sections of arthropods within the epidermis is often diagnostic for this disease, identifying mite species on histology can be problematic in hosts that may be infested by multiple species ([@bib145]; [@bib133]; [@bib162]; [@bib142]). Conventional and real-time polymerase chain reaction targeting the 16S ribosomal RNA, rRNA, ITS-2, and/or COI genes, as well as microsatellites, has been successfully utilized to identify *S. scabiei* DNA from skin scrapings in numerous animal species and humans ([@bib200]; [@bib78]; [@bib7]; [@bib141]). To reduce the requirement of capturing wildlife for testing, an assay to detect *Notoedres* spp. in the feces of bobcats was created, but similar techniques for the detection of *S. scabiei* in bears was unsuccessful at mite detection ([@bib181]; [@bib142]). PCR may be more a sensitive technique than cytology in cases where there is a low mite burden, such as in dogs and foxes; histology may also provide evidence of infestation but is considered less specific ([@bib133]; [@bib51]). More recently, a loop-mediated isothermal amplification (LAMP) assay was developed to rapidly diagnose mange ([@bib74]).

Several approaches can be used to investigate mange and mite exposure in populations. Serological tests can be useful to determine previous exposure to *S. scabiei*, but may not differentiate past exposure with current clinical disease. Similarly, its usefulness for individuals can be limited due to unknown time of initial exposure, possible differences in individual immune responses, and unknown applicability for commercially available assays for use in wildlife species. An enzyme-linked immunosorbent serologic assay (ELISA) has been developed for use in dogs and pigs for the detection of antibodies against *S. scabiei*. This and similar assays have been evaluated in many other wild and domestic animal taxa with variable results (e.g., [@bib34]; [@bib33]; [@bib31]; [@bib89]; [@bib77]; [@bib150]; [@bib142]). More recent techniques reported to diagnose sarcoptic mange in wildlife include a dot-ELISA for use in rabbits and has shown to be a simple, quick, and convenient way to accurately diagnose the disease ([@bib208]). An indirect ELISA, as well as a Western blot assay, has been used on lung extract and pleural fluid from animals that died prior to blood collection, allowing testing to be performed on animals that may not have died as recently or when serum is unavailable ([@bib95]). Serology can be complicated by cross-reactivity, particularly in wildlife, due to infestation by closely-related mite species ([@bib20]; [@bib21]).

Additional methods to monitor the prevalence, distribution, and consequences of mange in wild populations have been investigated. Detector dogs have been trained to find animals with sarcoptic mange in an attempt to detect cases and control the disease in populations of Alpine chamois (*Rupicapra rupicapra rupicapra*) and Alpine ibex (*Capra ibex*) ([@bib2]). Radio-collaring affected animals can show the impacts of mange on multiple individuals, including evidence of a drastic reduction in home-range sizes of affected raccoon dogs (*Nyctereutes procyonoides)* ([@bib188]). Camera traps have been used to monitor mange distribution in wildlife. This technique has become popular because it likely reduces the bias of clinically-ill animals being more likely to be shot or caught ([@bib40]). Camera traps have been used to estimate prevalence of sarcoptic mange in coyotes (*Canis latrans*), feral swine, and white-tailed deer (*Odocoileus virginianus*), but only severe cases of mange were consistently diagnosed, and mild cases often went undetected ([@bib37]). Camera traps have also been used to monitor mange in raccoon dogs in Japan, wolves (*Canis lupus*) in Italy and Spain, and bare-nosed wombats (*Vombatus ursinus*) in Australia ([@bib137]; [@bib29]; [@bib81]; [@bib160]). Thermal imaging for tele-diagnosis and physiological consequences of mange in Spanish ibex and gray wolves were also explored ([@bib8]; [@bib46]). However, imaging techniques are sensitive but lack specificity as this approach cannot distinguish between mange and other causes of skin disease or alopecia nor determine the species of mite potentially involved.

3.3. Management and treatment {#sec3.3}
-----------------------------

There are several approaches that have been used to manage sarcoptic mange in free-ranging wildlife, and each approach has advantages and disadvantages. Wildlife managers can attempt to reduce the likelihood of transmission of *S. scabiei* between hosts by reducing unnatural contacts between individuals (including minimizing artificial feeding), by maintaining biosecurity when trapping, handling, or transporting diseased wildlife, emphasizing prevention of a novel pathogen introduction, or by treatment and rehabilitation of individual animals ([@bib203]; [@bib178]; [@bib195]). Additionally, transmission studies show a lack of evidence for density-dependent transmission, although it is likely context-dependent (i.e., more density-dependent in some systems and frequency-dependent in others) ([@bib59]). There is little research on methods and efficacy of managing mange in free-ranging wildlife without treatment. Hunting animals or reducing densities alone may not halt the disease spread because animals may move more into newly-created territories ([@bib106]). Dogs able to find carcasses and live animals affected with mange allows removal or treatment of those individuals as means to prevent additional transmission of the parasite and more accurate monitoring of the population effects of mange, but this technique would not be feasible in many susceptible hosts ([@bib2]).

Additionally, one should consider whether attempted management of an endemic disease in a population that is considered healthy from a conservation standpoint should be pursued. If management of sarcoptic mange in wildlife is being considered, the actions should be tailored to the biology of the host affected. For example, if dens or burrows are a significant source of transmission in some canids or wombats, the approach would be different compared to bears where dens are unlikely to be a source of infestation ([@bib111]; [@bib117]; [@bib131]).

Managing mange in domestic species typically involves preventive treatments or the use of approved drugs for treatment of clinical cases by a veterinarian. Numerous publications regarding various treatment regimens have been published for sarcoptic mange in livestock and companion domestic animals including cats, goats, dogs, pigs, and alpacas ([@bib93]; [@bib94]; [@bib197]; [@bib50]; [@bib110]; [@bib194]; [@bib25]; [@bib28]; [@bib152]). However, there is limited information regarding the approved use of any of these treatments for use in free-ranging wildlife.

Treatment of mange in free-ranging wildlife is controversial, but has been conducted for a variety of reasons, including animal welfare concerns, threatened or endangered species, or for research purposes. [@bib155] recently provided a review on treatment of sarcoptic mange in wildlife and noted that most studies have been performed in Australia, Africa, and Europe. Based on their review, ivermectin applied subcutaneously for multiple doses between 200 and 400 μg/kg was the most successful and common treatment approach used in these studies, but fluralaner, amitraz, and phoxim were successfully used in some studies. Overall success of treatment was often influenced by severity of disease and number of dosages with greater number of doses given often associated with treatment success ([@bib103]; [@bib122]). Additionally, supportive care with the use of fluids and antibiotics also improved the treatment success in captive raccoon dogs ([@bib99]). Two studies that showed a failure of resolution of clinical signs were from moderately to severely-affected animals as well as from single-application of ivermectin and topical selamectin ([@bib130]; [@bib180]).

The authors of the review ([@bib155]) also acknowledged the lack of randomized control trials as well as minimal post-treatment monitoring of wildlife species to determine treatment efficacy and possible re-infection. Their broad recommendations included treating only mild to moderately-affected animals and removing severely-affected individuals from the population. When deciding if treatment is appropriate, factors must be considered including possible side effects of the drugs, severity of disease, if multiple doses are required and can be delivered, the ability to provide supportive care, ability to monitor or data suggesting post-treatment success, Animal Medicinal Drug Use Clarification (AMDUCA) and withdrawal time compliance in animals that may enter the food chain, potential for development of drug resistance, determining if the animal is truly cleared of infection or becomes a subclinical carrier, and if the animal is being translocated to a mange-free area ([@bib47]; [@bib190]; [@bib155]). In several instances involving species of special concern, studies have shown treatment can lead to population recovery ([@bib119]; [@bib82]; [@bib103]; [@bib51]). However in most scenarios, it may be more important to ask the question 'is treatment warranted' rather than 'which treatment is warranted.'

4. Mange in North American wildlife {#sec4}
===================================

4.1. Host range {#sec4.1}
---------------

Globally, it is estimated that *S. scabiei* affects more than 100 species of mammals representing a wide variety of taxa including canids, ungulates, marsupials, felids, suids, rodents, and primates. In North America, the number of free-ranging species reported to develop clinical sarcoptic mange is less than in other continents, and canids are the hosts primarily affected, particularly at the population-level ([Fig. 3](#fig3){ref-type="fig"}). Sarcoptic mange in other continents more commonly affects other taxa including cervids, bovids, felids, rodents, and mustelids ([@bib32]). For example, in Europe, sarcoptic mange is considered one of the most common causes of mortality in chamois and Spanish ibex, but also affects numerous other bovids, cervids, mustelids, and felids including many species that are also present in North America but have not been reportedwith sarcoptic mange ([@bib119]; [@bib154]; [@bib67]; [@bib159]; [@bib101]). A wide variety of species have been reported to develop clinical disease in Africa including giraffes, gorillas, lions, and cheetahs, among many other cervids ([@bib210]; [@bib127]; [@bib84]; [@bib1]), and Australian wildlife that are affected are primarily wombats, wallabies, and dingoes ([@bib72]; [@bib170]). This contrasts with North America where sarcoptic mange in cervids and bovids is rare, but rather these taxa tend to develop mange due to *Chorioptes* or *Psoroptes* while felids develop mange due to *Notoedres cati* ([@bib24]; [@bib129]; [@bib71]). A summary of the species documented to be infested by *S. scabiei* in North America is described in [Table 1](#tbl1){ref-type="table"}. In some reports, morphological features specific to *S. scabiei* were not thoroughly described, and there is possibility of mis-identification. [@bib221] also provide a map showing the distribution of hosts in North America documented to have sarcoptic mange.Fig. 3North American mammals with clinical sarcoptic mange. (A) Red fox with lesions on the face. (B) The same red fox showing a close up of the hyperkeratosis fissures in the skin. (C) Coyote with alopecia on the head and neck. (D) Gray wolf showing alopecia on the head, flanks, and hind limbs (Photo credit: Yellowstone Wolf Project/National Park Service). (E) Black bear in a culvert trap showing severe alopecia and skin thickening on the face, ears, and forelimb. (F) Black bear showing additional crusting and alopecia on the ears, flank, and muzzle; inset: close-up of hyperkeratotic and crusted skin.Fig. 3Table 1Published host records and selected geographic records for *Sarcoptes scabiei* in free-ranging North American wildlife.Table 1HostState/ProvinceSource**Canidae**Kit fox (*Vulpes macrotis mutica*)California, USA[@bib51]Gray wolf (*Canis lupus*)Alberta, Canada[@bib88]Multiple States, USA[@bib204]Wisconsin, USA[@bib205]Montana/Wyoming, USA[@bib96]Multiple States, USA[@bib5]Alaska, USA[@bib46]Coyote (*Canis latrans*)Wisconsin, USA[@bib193]Alberta, Canada[@bib192]Louisiana/Texas, USA[@bib144]Oklahoma/Wyoming/Kansas, USA[@bib121]Arizona, USA[@bib85]Kansas, USA[@bib97]South Dakota, USA[@bib42]Illinois, USA([@bib202])Red wolf (*Canis rufus*)Louisiana, USA[@bib144]Mexican wolf (*Canis lupus baileyi*)Arizona, USA[@bib96]Red fox (*Vulpes vulpes*)Ohio, USA[@bib138]Pennsylvania, USA[@bib148]Wisconsin, USA[@bib193]New York[@bib183]Various states, USA[@bib185]New Brunswick/Nova Scotia, Canada[@bib173]Various states, USA[@bib108]Alberta, Canada[@bib196]Virginia, USA[@bib98]Illinois, USA[@bib83]Gray fox (*Urocyon cinereoargenteus*)New York, USA[@bib184]Pennsylvania, USA[@bib148]**Cervidae**White-tailed deer (*Odocoileus virginianus*)Texas, USA[@bib37]**Ursidae**American black bear (*Ursus americanus*)Michigan, USA[@bib164]Pennsylvania, USA[@bib141]Virginia, USA[@bib195]**Procyonidae**Raccoon (*Procyon lotor*)Michigan, USA[@bib70]**Mustelidae**Fisher (*Martes pennanti*)Maine, USA[@bib134]**Suidae**Feral swine (*Sus scrofa*)Various southeastern states, USA[@bib174]**Erethizontidae**North American porcupine (*Erethizon dorsatum*)Maine, USA[@bib140]Pennsylvania, USA[@bib141]**Sciuridae**Fox squirrel (*Sciurus niger*)Michigan, USA[@bib70]**Leporidae**Swamp rabbit (*Sylvilagus aquaticus*)North Carolina, USA[@bib186]**Muridae**House mouse (*Mus musculus*)New York, USA[@bib115]**Bovidae**Bighorn sheep (*Ovis canadensis canadensis*)Western Canada[@bib45]

Early reports of epizootics in North American wildlife include outbreaks in red foxes in Ohio and Wisconsin ([@bib138]; [@bib193]). The mite was likely introduced into Montana, USA and Alberta, Canada through the intentional use of the mite to control coyote and wolf populations ([@bib100]; [@bib145]). In Montana, this 'experiment' was sanctioned by the state government and involved the State Veterinarian inoculating 200 wolves and coyotes in various counties in Montana; later, coyotes with suspected mange were reported in Wyoming, but it is unclear if the spread was related to the initial introduction ([@bib100]). Since then, mange has been observed in wild canids across the country and is considered endemic in many of these species ([@bib5]; [@bib32]; [@bib42]; [@bib97]; [@bib108]).

In North America, populations of red foxes, coyotes, and gray wolves appear to experience epizootics every thirty to forty-five years ([@bib147]). Mild cases of mange have been recently reported in Texas in white-tailed deer but are presumed to not be contributing to morbidity or mortality ([@bib37]). There are several examples of sarcoptic mange in novel hosts in the North America. The federally endangered kit fox (*Vulpes macrotis mutica*) has increased mortality in an urban, high-density population in Bakersfield, California ([@bib51]; [@bib156]). The case fatality rate in this population may be as high as 100%.

4.2. Foxes {#sec4.2}
----------

Red foxes are one of the most widespread canid species globally and are highly susceptible to sarcoptic mange ([@bib108]). The majority of research on mange in red foxes has occurred in Europe, where the disease has affected this species since the late 1600s ([@bib75]). The red fox population in Bristol, United Kingdom (UK) is arguably the most studied fox population in the world, largely as a result of ongoing mange dynamics research in this group ([@bib23]; [@bib179]). Several examples of severe red fox population impacts have been reported after the *S. scabiei* introduction or acute outbreaks, including the likely extinction of red foxes from a Danish island and severe population declines in Bristol, UK ([@bib119]; [@bib90]; [@bib107]).

In North America, reports of mange in red foxes are often sporadic, isolated, and rarely associated with recognized severe population impacts. These reports are primarily limited to the eastern United States ([@bib138]; [@bib148]; [@bib193]; [@bib185]; [@bib108]; [@bib83]). In some of these studies, small declines in red fox numbers were reported after acute mange outbreaks, but there was also evidence of recovery of some affected individuals ([@bib193]; [@bib185]).

Red foxes in urban settings in North America, similar to other continents, were more likely to develop disease and die from mange compared to rural populations, which may be influenced by exposure difference or detection bias ([@bib83]; [@bib179]). Behavioral changes were reported in red foxes including a decline in activity, loss of fear of humans, and lower likelihood of dispersal ([@bib193]; [@bib185]). Mortality can occur as quickly as 3--4 months following infection ([@bib182]). Foxes with mange also generally are in worse nutritional condition compared to foxes without mange, and they lose more mass compared to affected coyotes and wolves ([@bib193]; [@bib192]; [@bib145]; [@bib147]; [@bib130]; [@bib52]). In one study in the UK, foxes with mange survived one fifth as long as foxes without mange ([@bib130]).

There are data to suggest that host-parasite adaptation can occur. Serologic testing of red foxes in Norway showed that the ratio of seropositive-mange negative foxes to seropositive-mange positive foxes increased significantly ten years following the initial outbreak confirming that either the fox or the parasite had adapted and fewer clinical cases were observed as a result ([@bib52]). This adaptation likely has or is occurring in North American foxes, but no studies have been performed in this continent. Interestingly, clinical sarcoptic mange is extremely rare in gray foxes (*Urocyon cinereoargenteus*) despite this species being sympatric with red fox throughout much of the United States ([@bib148]; [@bib184]; [@bib53],[@bib54]). There are no known reports of mange in swift foxes (*Vulpes velox*), the reason for which is unknown.

4.3. Coyotes {#sec4.3}
------------

Coyotes with sarcoptic mange have been reported in Alberta, Canada and Montana, USA since the early 1900\'s, southern Texas in the 1920s, and in the mid-western United States since the 1950\'s ([@bib193]; [@bib145]; ). The expansion of sarcoptic mange in coyotes is possibly associated with the expanding populations of the host ([@bib92]). Most of the recent publications regarding mange in coyotes in North America centered around urban populations in Edmonton, Canada and several outbreaks in southern Texas between 1975 and 1995. However, isolated reports or small epizootics of mange in coyotes have been reported in multiple areas of North America, including up to 25% of coyotes in British Columbia showing signs of mange ([@bib45]; [@bib193]; [@bib182]; [@bib85]; [@bib97]; [@bib42]). Mange has likely occurred in most areas where coyotes exist in North America.

Several studies have looked at behavior changes in coyotes with mange. Coyotes with mange showed less avoidance of residential areas, particularly during the day, and preferred resource sites with anthropogenic food and bedding sources compared to individuals without mange ([@bib126]). In one study, coyotes with mange were more likely to use residential habitat prior to mange-induced mortality, particularly in the winter ([@bib202]). Coyotes with skin disease presumed to be from mange were more likely to access urban compost piles, had larger home ranges, and were more active during the day compared to clinically normal animals ([@bib124]; [@bib125]). Other studies have shown that no differences in home range between coyotes with or without mange ([@bib97]; [@bib42]). Similarly, coyotes with mange were not observed changing their home ranges between years ([@bib42]). Urban coyotes were more likely to have mange, be in poor physical condition, and were more likely to show conflict-prone behavior compared to rural coyotes ([@bib123]). Studies in other areas have shown that coyotes with mange stayed closer to carrion food sources than coyotes without mange, and carrion food sources made up a larger percentage of diet in coyotes with mange ([@bib192]). Severely affected individuals were shown to be listless and lacked appropriate fear of humans ([@bib193]). During mange outbreaks, coyotes were less likely to reproduce compared to years with less mange ([@bib145]).

Pence and Windberg described two epizootics of mange in coyotes in southern Texas ([@bib145]; [@bib147]). At the peak of the epizootic in the early 1980s and 1990s, as many as 60 and 80% of coyotes in southern Texas had mange, respectively, depending on the year ([@bib145]; [@bib147]). Despite over 70% mortality occurring in one study, no long-term population impacts were apparent ([@bib147]). Variation likely occurs however, as the percentage of coyotes with mange at the peak of an epizootic in another study was 32% ([@bib97]). These studies hypothesized that the outbreaks were cyclical and were caused by a virulent strain of the mites enhanced by a high coyote density and social behaviors, although no genetic analyses were performed on the mites. One study followed a clinically-normal male coyote that mated with a female coyote with mange. The male never developed any signs of mange, suggesting some animals are exposed but do not develop observable disease ([@bib97]). A study of urban coyotes in Chicago, Illinois (USA) showed that mange was endemic in the population and did not affect annual survival rates ([@bib202]).

In multiple studies, the number of cases of healing/resolving mange in coyotes was low suggesting either high mortality in severely affected animals that do not recover or that coyotes are less susceptible to severe disease compared to red foxes ([@bib192]; [@bib145]). However, multiple cases of coyotes with mange that survive have been reported, and mild disease can likely occur in this species ([@bib147]; [@bib42]). Coyotes could also be exposed to mites without infestation becoming established, further complicating estimations of mortality rate. Mange-specific mortality varied across studies but was as high as 55% in one study in South Dakota ([@bib145]; [@bib42]). Other studies have suggested that mange in coyotes was highest when population numbers were high and were immediately followed by sharp declines suggesting a density-dependent relationship ([@bib223]; [@bib192]). However, this relationship was not shown by [@bib145]. Adult male coyotes appear to be more likely to have mange than other sexes age-sex categories ([@bib192]; [@bib145]).

4.4. Wolves {#sec4.4}
-----------

Mange has been reported in gray wolves, Mexican wolves (*C. lupus baileyi*), and red wolves (*Canis rufus*) in North America since as early as 1889 but was likely present before this time ([@bib192]; [@bib96]). In Alberta, Canada during the 1970s, mange in gray wolves varied greatly between regions and years, and mange was implicated as limiting population growth during this time period ([@bib88]). Additionally, both wolves and coyotes had a higher prevalence of mange than the more commonly and severely affected red foxes. Sarcoptic mange was reported in wolves in the Midwestern USA in the 1990s and in the northern Rocky Mountains in the early 2000s ([@bib96]).

Sarcoptic mange was first reported in wolves in Yellowstone National Park (YNP) in January 2007 ([@bib171]). [@bib5] reported that mange spread outward following the initial introduction in YNP with highest risk of infection in packs closest to the index pack. Mange was reportedly highest in Yellowstone wolves during the winter months and dipped in the summer ([@bib6]). Additionally, pack size did not appear to be a risk factor for development of sarcoptic mange (rather, pack size appeared protective), but prevalence within a pack did seem to positively influence risk of transmission. In one study, no support was found for age, sex, or coat color as a risk factor for disease, and being previously infested was not associated with reduced risk of future infestations, which contrasts with data from Iberian wolves (*C. lupus signatus*) in Spain where yearlings were least likely to be diseased compared to adults and pups ([@bib137]; [@bib6]). In another study, wolf pups had a higher prevalence of mange in years where overall mange in the entire population was reduced ([@bib192]). In Alberta, peaks of sarcoptic mange in wolves followed peaks of mange in coyotes by one year ([@bib192]).

With social species, transmission is thought to occur more frequently within the group rather than between different groups as reported in the Yellowstone National Park wolf packs ([@bib5]). The overall spatial spread of the disease is consistent with pack to pack spread rather than repeated spillover events from outside of YNP. However, the spread of mange appeared to be highly variable within individual packs with some consistently presenting with low prevalence and severity while others suffered from rapid spread and high severity ([@bib5]). Coyotes also confirmed to have mange in wolf habitats possibly contributed to spreading the pathogen directly or indirectly ([@bib96]).

Changes in wolf behavior have been observed after the development of clinical disease potentially due to the increased metabolic demands associated with infestation and thermoregulation due to hair loss ([@bib166]). Wolves became weak and withdrew from the pack, stayed in areas of lower elevation and less snow, sought out shelter in rural areas near humans, and scavenged carcasses rather than wasting energy hunting ([@bib96]). Gray wolves with sarcoptic mange and subsequent hair loss have been shown to have a reduced ability to maintain appropriate thermoregulation. These physiologic changes result in an increased energy demand in clinically-affected wolves and results in wolves compensating by reducing their movement or only moving during warmer times of the day ([@bib46]). One report of wolves using porcupine dens in Wisconsin suggests that in extreme situations, animals with severe mange will seek out abnormal den sites ([@bib205]). Wolves with clinical disease were reportedly more likely to consume carrion than hunt for live prey compared to clinically-normal animals, and wolves being tracked also reduced their movements after severe disease developed ([@bib166]). Similar to coyotes, wolves had significantly less body fat and kidney fat if affected with mange compared to wolves without mange, although to a lesser extent ([@bib192]). Wolves and coyotes with mange had between 4 and 22% less body mass compared to animals without mange based on the severity of the disease ([@bib192]).

Multiple studies have shown that pup recruitment was significantly reduced when mange was prevalent in a wolf population ([@bib192]; [@bib96]). Mange was also implicated as being a potential cause for pack dissolution and negative growth rates in pack size ([@bib5]). The risk of mortality from mange decreased as the size of the pack increased, particularly if the pack-mates were mange-free, and as the elk-to-wolf ratio increased. Solitary animals with mange were at higher risk of mortality than those in a pack, and that a large pack size resulted in higher survival of wolves with mange ([@bib6]). The overall mange-associated mortality in North American wolves is unknown but estimates range between 27 and 34% in the midwestern USA but is estimated at 5.6% in Swedish wolves ([@bib96]; [@bib77]).

It was noted that not all wolves infested died from the disease or its secondary effects impacts, as survivability depended on disease severity and seasonal variation. Though many individual wolves died from mange or mange-related complications, only a few wolf packs in a few specific areas of Wyoming and Montana were impacted ([@bib96]). Wolves in Sweden in southern populations are more likely to have antibodies to *S. scabiei*, which may be related to their smaller territories in southern latitudes, as was observed in YNP in the USA, and the higher densities of red foxes ([@bib5]; [@bib77]). Packs of gray wolves in Sweden show that individual animals with clinical disease are often in contact with clinically-normal animals without antibodies to *S. scabiei*, which suggests unknown factors contribute to disease development in some individuals or in some packs ([@bib77]). However, several packs in close approximation to those with active mange remained mange-free, and similarly packs a larger distance from those with mange ultimately developed the disease, possibly from infested lone dispersers ([@bib5]). One study also showed that juveniles are more likely to be clinically-affected than older adults similar to other species such as red foxes ([@bib192]; [@bib145]; [@bib130]). Currently the northern mountain range wolf population continues to increase annually despite the spread of mange in the population ([@bib96]).

4.5. Bears {#sec4.5}
----------

Historically, American black bears were not considered a typical host for *S. scabiei*, and mange was rarely reported in North America ([@bib32]). A study describing three bears with sarcoptic mange in Michigan was the first report in 1984, and another isolated case was reported in Michigan in 2008 co-infected with the nematode *Pelodera strongyloides* ([@bib164]; [@bib69]). Numerous bears in New Mexico were observed to have dermatitis and hair loss but the cause of these lesions was not determined and was not associated with severe morbidity or mortality ([@bib44]). Beginning in the early 1990s, sarcoptic mange began to be more frequently detected in black bears in Pennsylvania ([@bib177]). Since then, the disease has expanded outward into New York, West Virginia, Virginia, and Maryland, and is a regular cause of morbidity and mortality in this region ([@bib132]).

The emergence of sarcoptic mange in bears is new relative to other species, and limited research on mange in bears has been performed. While urban areas are often associated with mange in other hosts, particularly canids, there was no association with impervious land cover and the likelihood of clinical mange in black bears ([@bib83]; [@bib179]; [@bib177]; [@bib124]). Genetic studies on the mites from bears in Pennsylvania and surrounding states indicated there are several haplotypes circulating in bears in the affected region, but a unique bear-specific genotype was not identified, although only two gene targets were investigated ([@bib141]). When diagnosing clinical mange in bears, skin scrapes appeared to be the most sensitive method for mite detection and identification, as previously mentioned, likely due to the high numbers of mites on bears compared to some other hosts ([@bib142]). Bears, unlike many other mange-susceptible hosts, are not a social species for much of the year, and transmission dynamics and outbreak epidemiology between individual bears are likely different compared to other hosts. Additional research in this system will help our understanding of mite adaptability, transmission, and host susceptibility. There are no known reports of sarcoptic mange in polar bears (*Ursus maritimus*) or grizzly bears (*Ursus arctos*) to the authors' knowledge.

5. Conclusions {#sec5}
==============

The severity of sarcoptic mange on wildlife populations is highly variable but has potential to cause severe impacts in naïve and susceptible populations. *Sarcoptes scabiei* has an unprecedented ability to cause disease in a wide host range involving taxa from five orders of mammals from North America. The continued expansion of hosts reported to develop this disease warrants continued research to better understand host susceptibility and disease epidemiology. Specifically, advances in modelling techniques that better quantify mange impacts on wildlife populations in North America, similar to what has been suggested for bare-nosed wombats in Australia, can provide valuable data on potential population effects, particularly since the impact on many species is likely under-appreciated due to general lack of surveillance ([@bib26]). Expanding hosts for *S. scabiei* could result in a similar expansion of the parasite and potential spillover into aberrant hosts. Additionally, anthropogenic effects on the environment, including climate change, increased contact with humans, domestic animals, and wild animals, and changes in environmental health may all contribute to mange outbreaks and host susceptibility. Decisions regarding mange management in wildlife populations requires a thorough evaluation of the risks and benefits of each management option while considering that taking no action may sometimes be the most appropriate. Factors that should be considered in any potential management decision include individual animal welfare, the conservation status of the species affected, and responsible treatment protocols.
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